• Home >
  • Publications >
  • Correction to: Full population results from the core phase of CompLEEment-1, a phase 3b study of ribociclib plus letrozole as first-line therapy for advanced breast cancer in an expanded population

Correction to: Full population results from the core phase of CompLEEment-1, a phase 3b study of ribociclib plus letrozole as first-line therapy for advanced breast cancer in an expanded population

1 Jan 2022Breast Cancer Research and Treatment

DOI : 10.1007/s10549-021-06374-6

Authors

Michelino De Laurentiis, Simona Borstnar, Mario Campone, Ellen Warner, Javier Salvador Bofill, William Jacot, Susan Dent, Miguel Martin, Alistair Ring, Paul Cottu, Janice Lu, Eva Ciruelos, Hamdy A. Azim, Sanjoy Chatterjee, Katie Zhou, Jiwen Wu, Lakshmi Menon-Singh, Claudio Zamagni